Artelon
Leading in Dynamic Ankle Stabilization
Leading in Dynamic Ankle Stabilization
Artelon is a pioneering company specializing in dynamic ankle stabilization, boasting a founding year of 2013. Their distinct focus lies in the dynamic augmentation of tendon and ligament reconstruction, leveraging specially designed bio-textiles to resiliently reinforce soft tissue repair. They uniquely prioritize the restoration of native motion, resistance against degradation of reconstruction strength, and support for tendon and ligament regeneration. With headquarters in the United States, Artelon operates in the Biotechnology, Health Care, and Manufacturing sectors. In their latest funding round, Artelon secured a significant $20.00M Series B investment on 24 May 2023, which was led by Vensana Capital. This injection of capital indicates a strong vote of confidence in the company's innovative approach to enhancing mobility and stability for individuals recovering from ankle-related injuries. For further insights, interested parties can explore the company's offerings by visiting their website or subscribing to the Artelon YouTube channel.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $20.00M | 1 |
|
24 May 2023 |
No recent news or press coverage available for Artelon.
We care about your data, and we'd love to use cookies make your experience better.
